Search clinical trials for: GKT137831

Total 5 results

Calliditas Therapeutics AB

Completed

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Type 2 Diabetes Mellitus With Diabetic Nephropathy

Australia, United States, Germany, Poland, Canada, Czech Republic
Calliditas Therapeutics AB

Completed

Study to Evaluate the Pharmacokinetics and Drug-Drug Interactions of Setanaxib in Healthy Adult Male and Female Subjects

Phase 1

France
Calliditas Therapeutics AB
Eurofins Optimed; York Bioanalytical Solution

Completed

Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets

Phase 1

France
Calliditas Therapeutics AB

Completed

Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.

Primary Biliary Cirrhosis

United States, Israel, Belgium, Germany, United Kingdom, Spain, Greece, Canada, Italy
University of Alabama at Birmingham
University of Michigan; Tulane University; Temple University

Recruiting

GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis (GKT137831)

Idiopathic Pulmonary Fibrosis

United States

3

Subscribe